Results 251 to 260 of about 72,847 (303)

Glucocorticoid-endocannabinoid crosstalk in the ventrolateral periaqueductal gray (vlPAG) promotes pain resolution. [PDF]

open access: yesNeuropsychopharmacology
Coutens B   +9 more
europepmc   +1 more source

(+)-Trans-Cannabidiol Is an Agonist at Human CB<sub>2</sub> Receptors. [PDF]

open access: yesPharmacol Res Perspect
Burtchaell PB   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Cannabinoids, cannabinoid receptors and tinnitus

Hearing Research, 2016
One hypothesis suggests that tinnitus is a form of sensory epilepsy, arising partly from neuronal hyperactivity in auditory regions of the brain such as the cochlear nucleus and inferior colliculus. Although there is currently no effective drug treatment for tinnitus, anti-epileptic drugs are used in some cases as a potential treatment option. There is
Paul F, Smith, Yiwen, Zheng
openaire   +2 more sources

Focus on cannabinoids and synthetic cannabinoids

Clinical Pharmacology & Therapeutics, 2016
The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a wealth of new information, suggesting the usefulness of state‐of‐the‐art on lato sensu cannabinoids. By modulating a plurality of neurotransmission pathways, the endocannabinoid system is involved in many physiological processes that are increasingly explored.
R, Le Boisselier   +3 more
openaire   +2 more sources

Cannabinoids and Gliomas

Molecular Neurobiology, 2007
Cannabinoids, the active components of Cannabis sativa L., act in the body by mimicking endogenous substances--the endocannabinoids--that activate specific cell surface receptors. Cannabinoids exert various palliative effects in cancer patients. In addition, cannabinoids inhibit the growth of different types of tumor cells, including glioma cells, in ...
Guillermo, Velasco   +8 more
openaire   +2 more sources

Cannabinoids

Current Drug Target -CNS & Neurological Disorders, 2005
Since the discovery of an endogenous cannabinoid system, research into the pharmacology and therapeutic potential of cannabinoids has steadily increased. Two subtypes of G-protein coupled cannabinoid receptors, CB(1) and CB(1), have been cloned and several putative endogenous ligands (endocannabinoids) have been detected during the past 15 years.
openaire   +2 more sources

Home - About - Disclaimer - Privacy